“…Recent studies have examined the cell-free mRNA expression of several genes, including TS [ 28 ], β-catenin [ 29 ], hTERT [ 26 , 30 , 31 ], CK19 [ 32 , 33 ], MUC1 [ 34 ], CXCR4 [ 35 ], Bmi-1 [ 35 ], Her-2 [ 36 ] and DKK1 [ 24 ], these studies have focused on the use of cell-free mRNA for early diagnosis, tumor staging and disease monitoring. In contrast, to the best of our knowledge, the present study is the first to examine the potential role of plasma mRNA for predicting docetaxel and pemetrexed chemosensitivity of solid tumors.…”